2017
DOI: 10.1016/j.soard.2017.09.121
|View full text |Cite
|
Sign up to set email alerts
|

BMI-based thromboprophylactic dosing of enoxaparin after bariatric surgery could be sub-optimal: Evidence for dosage adjustment by anti-Factor Xa in high-risk patients

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles